1-2 of 2
Adam Schayowitz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer

Free
Tadas Vasaitis, Aashvini Belosay, Adam Schayowitz, Aakanksha Khandelwal, Pankaj Chopra, Lalji K. Gediya, Zhiyong Guo, Hong-Bin Fang, Vincent C.O. Njar, Angela M.H. Brodie
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (8): 2348–2357.
https://doi.org/10.1158/1535-7163.MCT-08-0230
Published: 21 August 2008
View articletitled, Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer
Open the PDF for Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer in another window
Journal Articles

Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro

Free
Adam Schayowitz, Gauri Sabnis, Vincent C.O. Njar, Angela M.H. Brodie
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (1): 121–132.
https://doi.org/10.1158/1535-7163.MCT-07-0581
Published: 17 January 2008
View articletitled, Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro
Open the PDF for Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro in another window